Painful Hematuria: Evaluation and Management
For a patient presenting with painful hematuria, immediately pursue urologic evaluation with cystoscopy and imaging (CT urography or ultrasound) to rule out urinary tract malignancy, stones, or infection—even if symptoms are self-limited—as pain does not exclude serious pathology and delays in diagnosis can worsen outcomes. 1
Initial Assessment and Risk Stratification
When evaluating painful hematuria, first distinguish between gross (visible) and microscopic hematuria, as this fundamentally changes your approach:
Confirm True Hematuria
- For dipstick-positive results: Confirm with microscopic urinalysis showing ≥3 RBCs per high-power field before initiating extensive workup 1
- Document pain characteristics: Location, severity, timing, and relationship to voiding
- Ask specifically about gross hematuria history: Even if currently microscopic, any history of visible blood changes risk stratification 1
Exclude or Treat Infection First
- Obtain urine culture even with negative dipstick, as lower bacterial counts can cause symptoms but may not show on routine urinalysis 2
- If urinary tract infection is present, treat appropriately and reassess—hematuria should resolve with infection treatment 3
- Critical caveat: If hematuria persists after treating infection, proceed with full urologic evaluation 3
Mandatory Urologic Referral Scenarios
Refer immediately for cystoscopy and imaging in these situations 1:
- Any gross hematuria (even if self-limited or single episode)
- Microscopic hematuria with pain in absence of confirmed benign cause
- Age >40 years with any confirmed hematuria
- Tobacco exposure history regardless of age (high bladder cancer risk) 2
- Persistent microscopic hematuria after infection treatment
Do NOT delay evaluation for anticoagulation
Patients on antiplatelet or anticoagulant therapy still require full hematuria workup—anticoagulation does not explain hematuria, it only unmasks underlying pathology 1
Diagnostic Imaging Strategy
The imaging approach depends on age and clinical presentation 4:
Patients ≤40 Years Old
- Microscopic hematuria with pain: Non-contrast CT (preferred) or ultrasound to detect stones
- Gross hematuria: Add cystoscopy to imaging
- Rationale: Stones are more common than malignancy in this age group (87% of stone patients had gross hematuria or ≥5 RBCs/HPF) 4
Patients >40 Years Old
- All cases: Pre- and post-contrast CT plus cystoscopy 4
- Rationale: Cancer risk increases significantly with age—in one series, 31 malignancies occurred in patients >40 vs. only 1 in younger patients 4
- CT has 92% sensitivity and 93% specificity for detecting urologic pathology 4
What NOT to Do
Avoid these low-value practices 1:
- Do not obtain urinary cytology or urine-based molecular markers in initial evaluation
- Do not screen asymptomatic adults with urinalysis for cancer detection
- Do not dismiss hematuria as insignificant just because patient is on anticoagulation
Special Consideration: Interstitial Cystitis/Bladder Pain Syndrome
If urologic evaluation is negative and patient has chronic pain (≥6 weeks) with frequency, urgency, and bladder/pelvic discomfort, consider IC/BPS 2:
- Requires negative urine cultures documented over time
- Document voiding frequency (use voiding diary), pain severity, and relationship to bladder filling
- Cystoscopy indicated if Hunner lesions suspected (these patients respond well to treatment) 2
- Most IC/BPS patients do NOT have diagnostic cystoscopic findings except Hunner lesions 2
Critical Pitfalls to Avoid
- Assuming pain means "just infection": Stones and tumors frequently present with pain and hematuria together
- Inadequate follow-up: Studies show majority of primary care patients with microscopic hematuria lack appropriate urologic referral—almost 60% are high-risk but don't receive guideline-concordant evaluation 5
- Age bias: Don't skip comprehensive evaluation in younger patients with risk factors (smoking, gross hematuria)
- Single normal urinalysis: Hematuria can be intermittent; if clinical suspicion remains high, repeat testing or proceed with imaging
The fundamental principle: Painful hematuria represents urologic pathology until proven otherwise, and delayed diagnosis of malignancy or obstructive uropathy directly impacts mortality and morbidity. 6